Lower Extremity Mobility for CAI (NCT07584746) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Lower Extremity Mobility for CAI
40 participantsStarted 2026-06
Plain-language summary
This study will be conducted to determine the effect of addition of ankle mobility versus hip mobility exercises to traditional rehabilitation to patients with chronic ankle instability. the main purpose is to answer the following question:
* out of these interventions which would better improve lower limb flexibility, range of motion, severity of functional instability and dynamic postural control?
Researcher will compare between ankle mobility versus hip mobility exercises
Participants will be allocated in 2 experimental groups:
* group A will include 20 patients receiving conventional physiotherapy in addition to ankle mobility exercises
* group B will include 20 patients receiving conventional physiotherapy in addition to hip mobility exercises
Patients will receive 3 sessions per week for 6 weeks in a physiotherapy outpatient facility for both groups
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults (18-30 years old) with chronic ankle instability
* Patient's Body mass index (BMI) will range from 18.5- 29.9 kg/m2
* A history of at least one ankle sprain with the initial sprain occurring 12 months prior to study
* Most recent injury 3 months prior to start of treatment with at least one day of interrupted desired physical activity and associated inflammatory symptoms (pain, swelling, etc.).
* A history of previous giving way and/or recurrent sprain, and/or feeling of instability to injured ankle.
* Cumberland Ankle Instability Tool: score of ≤ 24.
Exclusion Criteria:
* Other lower extremity injury surgery 6 months before testing
* Patient suffered an acute sprain in the previous 6 weeks to the start of the study.
* History of neuromuscular disorders.
* Systemic diseases that affect balance.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.